← All indications
Neoplasms, Unknown Primary
Metastases in which the tissue of origin is unknown.
Drugs by status
Phase 3 trials (5)
Phase 2 trials (9)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (40)
- Spectrum Pharmaceuticals
- Foundation Medicine
- Roche
- Merck
- Genentech
- Merck KGaA
- Sanofi-Synthelabo
- Valerio
- Fondazione del Piemonte per l'Oncologia
- British Columbia Cancer Agency
- National Cancer Institute (NCI)
- University of Pennsylvania
- Cornell University
- Harvard University
- Eastern Cooperative Oncology Group
- Temple University
- NHS Lothian
- Ohio State University
- Rutgers University
- Southwest Oncology Group
- Stanford University
- University of Edinburgh
- University of Heidelberg
- University of Medicine and Dentistry of New Jersey
- University of Michigan
- University of South Florida
- University of Toronto
- Mayo Clinic
- University of Calgary
- University of Chicago
- +10 more
Organization Involved with Phase 1 Indications (9)